Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail)

v3.22.2.2
NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Common stock issued under the Backstop Agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 9,600,031 0 9,600,031 0
Restricted stock grants with only service conditions        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 3,840,501 0 3,468,900 0